Stock listing
EYPT Stock Price, News, Filings & Events — Eyepoint, Inc.
Selected listing: EYPT · NASDAQ · USD · US
This page tracks Eyepoint, Inc.'s EYPT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EYPT:NASDAQ. EYPT:NASDAQ is the stock-level entry point for investors researching Eyepoint, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Eyepoint, Inc. is a public company traded under the ticker EYPT in the American market. The company has a market capitalization of approximately $1.02 billion. Eyepoint focuses on developing innovative therapeutics for eye diseases, aiming to improve patient outcomes through advanced drug delivery systems.
- Ticker
- EYPT:NASDAQ
- Asset type
- Stock
- Market cap
- $386.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Eyepoint, Inc. EYPT:NASDAQ stock context
This page tracks Eyepoint, Inc.'s EYPT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EYPT:NASDAQ. EYPT:NASDAQ is the stock-level entry point for investors researching Eyepoint, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Eyepoint, Inc. is a public company traded under the ticker EYPT in the American market. The company has a market capitalization of approximately $1.02 billion. Eyepoint focuses on developing innovative therapeutics for eye diseases, aiming to improve patient outcomes through advanced drug delivery systems.
Latest news from Eyepoint, Inc.
EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments
August 5, 2026
EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)
July 30, 2026
EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer
July 13, 2026
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of M...
May 14, 2026
EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments
May 6, 2026
Eyepoint, Inc. earnings calls
EyePoint, Inc. (EYPT) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
EyePoint, Inc. (EYPT) Q4 2025 Earnings Call
March 4, 2026 · Replay with transcript and chapters
EyePoint, Inc. (EYPT) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
EyePoint, Inc. (EYPT) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
EyePoint, Inc. (EYPT) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
EyePoint, Inc. (EYPT) Q4 2024 Earnings Call
March 5, 2025 · Replay with transcript and chapters
Research Eyepoint, Inc.
Eyepoint, Inc. investor report
Review AI stock analysis and investor report context for EYPT:NASDAQ.
Eyepoint, Inc. company profile
View the public company page for Eyepoint, Inc. on 6ix.
Eyepoint, Inc. news
Read company news and market updates connected to Eyepoint, Inc..
Eyepoint, Inc. investor events
Find investor webinars, events, and replay context for Eyepoint, Inc..
Alternate listings
A2QJRU:LSX
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
PV3B:GETTEX
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
A2QJRU:LS
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
EYPT:BOATS
US · USD
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
PV3B:TRADEGATE
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
PV3B:DUS
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
PV3B:FWB
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
PV3B:MUN
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.
PV3B:SWB
DE · EUR
Alternate listing for Eyepoint, Inc.; the primary context on this page is EYPT:NASDAQ.